Klaus Kuehlcke

Transfer of Autologous Gene-modified T Cells in HIV-infected Patients with Advanced Immunodeficiency and Drug-resistant Virus

Jan van Lunzen, Tobias Glaunsinger, Ingrid Stahmer et al. · Molecular Therapy · 2007 · 138 citations · Full text

Gene-modified Cells, Gene Marking, Human Retrovirus +15

A new PG13-based packaging cell line for stable production of clinical-grade self-inactivating γ-retroviral vectors using targeted integration

Rainer Loew, Yves Meyer, Klaus Kuehlcke et al. · Gene Therapy · 2009 · 50 citations

Stable Production, Medicine, Immunology +6

Lentivirus-induced ‘Smart’ dendritic cells: Pharmacodynamics and GMP-compliant production for immunotherapy against TRP2-positive melanoma

Bala Sai Sundarasetty, Lucas Chan, D. Christopher Darling et al. · Gene Therapy · 2015 · 44 citations · Full text

Immunology, Immunologic Mechanism, Immunotherapeutics +16

Improved post-transcriptional processing of an MDR1 retrovirus elevates expression of multidrug resistance in primary human hematopoietic cells

R Knipper, Klaus Kuehlcke, Bernhard Schiedlmeier et al. · Gene Therapy · 2001 · 38 citations

Human Retrovirus, Immunology, Post-transcriptional Processing +5

Retrovirus-Mediated Gene Transfer in Human Primary T Lymphocytes Induces an Activation- and Transduction/Selection-Dependent TCR-B Variable Chain Repertoire Skewing of Gene-Modified Cells

Sylvie Coito, Delphine Sauce, Anne Duperrier et al. · Stem Cells and Development · 2004 · 23 citations